Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients.
暂无分享,去创建一个
J. Gu | Zhiqiang Zhang | Huifang Tian | Jing Shen | T. Zhan | Ming Li | D. Ji | Yun-feng Yao
[1] Yipeng Wang,et al. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. , 2012, Blood.
[2] D. Wågsäter,et al. Pigment Epithelium-Derived Factor Expression in Colorectal Cancer Patients , 2010, Cancer investigation.
[3] S. Cai,et al. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening. , 2010, Journal of proteome research.
[4] C. Le Page,et al. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer , 2010, British Journal of Cancer.
[5] Yanlei Ma,et al. Proteomics Identification of Desmin as a Potential Oncofetal Diagnostic and Prognostic Biomarker in Colorectal Cancer* , 2009, Molecular & Cellular Proteomics.
[6] Hui Yue,et al. Proteome analysis of aflatoxin B1‐induced hepatocarcinogenesis in tree shrew (Tupaia belangeri chinensis) and functional identification of candidate protein peroxiredoxin II , 2008, Proteomics.
[7] A. Iannone,et al. Proteomic analysis of early urinary biomarkers of renal changes in type 2 diabetic patients , 2008, Proteomics. Clinical applications.
[8] Kathleen R. Cho,et al. Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas , 2008, Proteomics. Clinical applications.
[9] M. Duffy,et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. , 2007, European journal of cancer.
[10] Daniel F Hayes,et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Fuchu He,et al. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project , 2005, Proteomics.
[12] P. Ascierto,et al. Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases , 2005, Melanoma research.
[13] J. Casal,et al. Proteomic expression analysis of colorectal cancer by two‐dimensional differential gel electrophoresis , 2005, Proteomics.
[14] R. Caprioli,et al. Proteome analysis of human colon cancer by two‐dimensional difference gel electrophoresis and mass spectrometry , 2004, Proteomics.
[15] M. Tisdale,et al. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. , 2004, Biochimica et biophysica acta.
[16] J. Jenkins,et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Noh,et al. Overexpression of peroxiredoxin in human breast cancer. , 2001, Anticancer research.
[18] W. Demark-Wahnefried,et al. Zinc α-2-Glycoprotein Is Expressed by Malignant Prostatic Epithelium and May Serve as a Potential Serum Marker for Prostate Cancer , 2001 .
[19] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[20] P. Courchesne,et al. Two‐dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: Toward a human mitochondrial proteome , 1998, Electrophoresis.
[21] J. Tombran-Tink,et al. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.
[22] M. Niwa,et al. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[23] M. Niwa,et al. Human seminal plasma Zn-α2-glycoprotein: Its purification and properties as compared with human plasma Zn-β2-glycoprotein☆ , 1990 .
[24] J. Tombran-Tink,et al. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. , 1989, Investigative ophthalmology & visual science.
[25] K. Schmid,et al. Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. , 1961, The Journal of biological chemistry.
[26] Garth H. Ballantyne,et al. Surgical Treatment of Liver Metastases , 2006 .
[27] J. Chang,et al. Identification of differentially expressed proteins during human urinary bladder cancer progression. , 2005, Cancer detection and prevention.
[28] C. López-Otín,et al. Zn-α2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters , 1993 .
[29] M. Chrétien,et al. The major 40‐kDa glycoprotein in human prostatic fluid is identical to Zn‐α2‐glycoprotein , 1987 .